Tweets by scisetglobal

OncoStudies

OncoStudies

ISSN: 2832-0395

OncoStudies aims to publish high quality original research work and provides a platform for scientists and academicians all over the world to promote, share, and discuss various novel aspects and methods in all areas of Oncology.

This journal serves the scientific community as a forum to discuss current developments in the area of aging research by exploring new innovations and application of genetic principles in Oncology and public policy to attain highest publishing quality standards.

OncoStudies is an open access, peer-reviewed, multidisciplinary, scholarly publishing journal, who publishes the contributions in the form of research articles, scientific reviews, clinical trial evidences, short communications, case reports etc. We provide digital object identifier (DOI), which is electronic identification code or tag for all manuscripts and serves international readers by publishing the original manuscripts and other related research work submitted by worldwide authors.

OncoStudies is open access; quarterly, online journal publishing mainly original Research Articles, Review, Short communications, Perspectives (Innovative teaching methods, innovative practice approach, novel models, debates, viewpoints), Invited articles, Case reports, Letter to Editor that contributes significantly to further the scientific knowledge predominantly devoted to reporting original contributions in various novel aspects and its application in all areas of Oncology.

OncoStudies also offering membership program, which enables academic and research institutions, societies, groups, funding organizations and corporations to actively support Open Access in scholarly publishing and also support the participation of its representatives and students in international conferences.

OncoStudies offers distinct benefits to academic, government, universities and corporate libraries as well as to authors, editors and readers upon associating with the Journal. 

We believe a manuscript is the ultimate form of contribution of a researcher for the betterment of the global community. Impactful research should be available to global readers with no hindrance. We never claim Publication Fees beyond the limit of the researchers.

Editorial Board

The initial manuscript handling persons are Editorial Board Members. The decision from them will be communicated to Editor-in-Chief/Managing Editor. If assertive comments from all ends, the manuscript will go for rigorous peer-review. In all the cases stated above, only the recognized experts in the respective field will be allowed to comment on the manuscript.

Peer Review

The single manuscript will be assigned to multiple reviewers and the most logical and elaborated comments will be accepted for evaluation. In no condition, peer-review process will be extended more than 14 days.

Managing Editor’s Role

Managing Editor's will follow up and provide adequate responses regarding the manuscript assigned to him/her. Managing Editor’s will not interfere in the decision-making process of the manuscript. In a critical situation, the managing editor will assign the manuscript to the additional reviewer in case the review process is delayed or lack of communication with the reviewer.

Rapid and Fast Publication

All segments of the manuscript processing-related communications are transparent, rapid, and effortless which in other way helps to complete the article processing within the promised timeline.

Submission Process

Authors may submit the manuscript either online or as an email attachment to submissions@sciset.com